RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
SD Biotechnologies Co Stock

SD Biotechnologies Co Liabilities 2024

SD Biotechnologies Co Liabilities

32.12 B KRW

Ticker

217480.KQ

ISIN

KR7217480003

In 2024, SD Biotechnologies Co's total liabilities amounted to 32.12 B KRW, a -65.59% difference from the 93.34 B KRW total liabilities in the previous year.

SD Biotechnologies Co Aktienanalyse

What does SD Biotechnologies Co do?

SD Biotechnologies Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing SD Biotechnologies Co's Liabilities

SD Biotechnologies Co's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating SD Biotechnologies Co's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing SD Biotechnologies Co's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

SD Biotechnologies Co's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in SD Biotechnologies Co’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about SD Biotechnologies Co stock

What is the level of liabilities of SD Biotechnologies Co this year?

SD Biotechnologies Co has a debt balance of 32.12 B KRW this year.

What were the liabilities of SD Biotechnologies Co compared to the previous year?

The liabilities of SD Biotechnologies Co have increased by -65.59% dropped compared to the previous year.

What are the consequences of high debt for investors of SD Biotechnologies Co?

High liabilities can pose a risk for investors of SD Biotechnologies Co, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in SD Biotechnologies Co?

Low liabilities mean that SD Biotechnologies Co has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of SD Biotechnologies Co affect the company?

An increase in liabilities of SD Biotechnologies Co can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of SD Biotechnologies Co affect the company?

A decrease in the liabilities of SD Biotechnologies Co can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of SD Biotechnologies Co?

Some factors that can influence the liabilities of SD Biotechnologies Co include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of SD Biotechnologies Co so important for investors?

The liabilities of SD Biotechnologies Co are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can SD Biotechnologies Co take to modify the liabilities?

To change its liabilities, SD Biotechnologies Co can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does SD Biotechnologies Co pay?

Over the past 12 months, SD Biotechnologies Co paid a dividend of 126.94 KRW . This corresponds to a dividend yield of about 25.38 %. For the coming 12 months, SD Biotechnologies Co is expected to pay a dividend of 0 KRW.

What is the dividend yield of SD Biotechnologies Co?

The current dividend yield of SD Biotechnologies Co is 25.38 %.

When does SD Biotechnologies Co pay dividends?

SD Biotechnologies Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of SD Biotechnologies Co?

SD Biotechnologies Co paid dividends every year for the past 0 years.

What is the dividend of SD Biotechnologies Co?

For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.

In which sector is SD Biotechnologies Co located?

SD Biotechnologies Co is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von SD Biotechnologies Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of SD Biotechnologies Co from 4/13/2018 amounting to 150 KRW, you needed to have the stock in your portfolio before the ex-date on 12/27/2017.

When did SD Biotechnologies Co pay the last dividend?

The last dividend was paid out on 4/13/2018.

What was the dividend of SD Biotechnologies Co in the year 2023?

In the year 2023, SD Biotechnologies Co distributed 0 KRW as dividends.

In which currency does SD Biotechnologies Co pay out the dividend?

The dividends of SD Biotechnologies Co are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von SD Biotechnologies Co

Our stock analysis for SD Biotechnologies Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of SD Biotechnologies Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.